[go: up one dir, main page]

EP3258263B1 - Cell analyzer and particle sorting method and device - Google Patents

Cell analyzer and particle sorting method and device Download PDF

Info

Publication number
EP3258263B1
EP3258263B1 EP15881526.6A EP15881526A EP3258263B1 EP 3258263 B1 EP3258263 B1 EP 3258263B1 EP 15881526 A EP15881526 A EP 15881526A EP 3258263 B1 EP3258263 B1 EP 3258263B1
Authority
EP
European Patent Office
Prior art keywords
signal
pulse width
scattered light
particles
reinforcement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15881526.6A
Other languages
German (de)
French (fr)
Other versions
EP3258263A4 (en
EP3258263A1 (en
Inventor
Bo YE
Guanzhen WANG
Yi Ye
Jiantao DI
Ying Zhang
Huan Qi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Mindray Bio Medical Electronics Co Ltd
Original Assignee
Shenzhen Mindray Bio Medical Electronics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Mindray Bio Medical Electronics Co Ltd filed Critical Shenzhen Mindray Bio Medical Electronics Co Ltd
Priority to EP21194141.4A priority Critical patent/EP3943912A1/en
Publication of EP3258263A1 publication Critical patent/EP3258263A1/en
Publication of EP3258263A4 publication Critical patent/EP3258263A4/en
Application granted granted Critical
Publication of EP3258263B1 publication Critical patent/EP3258263B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1429Signal processing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/49Scattering, i.e. diffuse reflection within a body or fluid
    • G01N21/53Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/149Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/016White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1402Data analysis by thresholding or gating operations performed on the acquired signals or stored data
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/12Circuits of general importance; Signal processing

Definitions

  • the present invention relates to a medical instrument, and more particularly to a cell analyser and a particle sorting method and device.
  • a blood cell analyser is an instrument that can detect cells in the blood. It can count and sort cells such as leucocytes (white blood cells, WBC), red blood cells, blood platelets, nucleated red blood cells and reticulocytes.
  • the most common method used by a blood cell analyser to detect leucocytes is a laser scattering method, in which by irradiating cell particles flowing through a detection region with light, optical signals reflected or scattered by various categories of particles are collected, and then the optical signals are processed and analysed so as to sort and count the leucocytes.
  • the collected optical signals may include three types of optical signals such as forward-scattered light, side-scattered light and fluorescence signals.
  • the forward-scattered light can reflect size information of the cell
  • the side-scattered light can reflect complexity of an internal structure of the cell
  • the fluorescence signal reflects the content of matters in the cell that can be dyed by a fluorescent dye, such as DNA and RNA.
  • detection processes are divided into different detection channels, such as a DIFF channel, a BASO channel and a NRBC channel.
  • the BASO channel is used to sort and count leucocytes, while a blood sample is treated with a chemical reagent, the total number of leucocytes is counted by means of side-scattered light and forward-scattered light, and a count of basophil granulocytes in the leucocytes is also provided.
  • the NRBC channel can be used to sort nucleated red blood cells after a blood sample is treated with a fluorescent reagent added therein.
  • the NRBC channel can provide a leucocyte count and a nucleated red blood cell count.
  • the interfering particles may be lipid granules or aggregated PLT (blood platelet) particles.
  • PLT blood platelet
  • PLT is a part of a blood ghost which is a cell debris structure formed after a sample pretreatment of a blood sample, in which cells such as red blood cells or platelets are subjected to a hypotonic treatment or treated with a reagent, resulting in cell membrane rupture.
  • the particle size is small, and the forward-scattered light signal is weak.
  • Fig. 1 shows a detection result of the NRBC channel, where an aggregated platelet cluster A1 overlaps with a leucocyte cluster B1 in the forward-scattered light and fluorescence signals.
  • Fig. 2 shows a detection result of the BASO channel, where leucocytes are sorted into a basophil granulocyte cluster A2 and a cluster B2 of other leucocyte particles including lymphocytes, monocytes, neutrophil granulocytes and eosinophil granulocytes.
  • lipid particles Due to the exist of lipid particles, a lipid granule cluster C2 overlaps with the cluster B2 of other leucocyte particles in a region D2 at a lower end of the forward-scattered light and side-scattered light signals, which may interfere with counting of leucocytes. It can be seen that the exist of these interfering particles in the blood sample will affect the accuracy of the detection results.
  • US 2008/0176274 A1 describes a method for classifying and counting leukocytes, which includes staining cells and obtaining scattered light peak intensities and scattered light widths of respective cells based on a measured first scattered light and obtaining scattered light intensities of the respective cells based on a measured second scattered light, and obtaining fluorescence intensities of the respective cells based on the measured fluorescence light. The cells are then classified based on the scattered light peak intensities and scattered light widths.
  • the invention relates to a particle sorting method, the method includes:
  • the invention also relates to a particle sorting device, the particle sorting device includes an optical signal acquisition unit for acquiring optical signals generated by particles irradiated with light in a blood sample when the sample passes through a detection region, the optical signals comprising at least two of forward-scattered light, side-scattered light and fluorescence; a pulse width acquisition unit for acquiring at least one pulse width of at least one of the optical signals; a sorting unit for distinguishing between a first category of particles and a second category of particles according to a scatter diagram; a calculating unit for selecting at least one of the optical signals as a selected optical signal, and using a signal intensity of the selected optical signal and the pulse width to calculate at least one reinforcement signal, depending on the number of pulse widths and/or signal intensities used for calculating the at least one reinforcement signal, the at least one reinforcement signal is a single reinforcement signal or a plurality of reinforcement signals including at least another reinforcement signal; and a scatter diagram generating unit for forming the scatter diagram based on a reinforcement signal of the at least
  • a new reinforcement signal is formed by combining a function of a certain optical signal and a function of a pulse width signal so that the difference between the first category of particles and the second category of particles in the reinforcement signal is increased, and a new scatter diagram is generated based on the reinforcement signal.
  • a particle passing through a detection region would generate a pulse, and the width of the pulse (hereinafter referred to as pulse width) can reflect the time during which the particle passes through the detection region, and thus can characterize the size of the particle.
  • Fig. 3 shows a schematic diagram of a detected pulse, where a pulse signal is excited when a particle passes through a detection region. The pulse width is from the start of the pulse to the end of the pulse, and the pulse width signal is actually the time during which the particle passes through the detection region.
  • the width of a pulse generated by aggregated particles when passing through the detection region is relatively large. It is theoretically possible to distinguish between aggregated blood platelet particles and leucocytes by pulse width. However, due to the fact that the number of blood platelets aggregated together is different, the blood platelet clusters range widely in particle size, some aggregated blood platelet particles of a larger size will overlap with leucocyte groups. Therefore, the leucocytes and the aggregated blood platelet particles cannot be distinguished from each other favourably by pulse width.
  • lipid granules in a blood sample because the size thereof varies, the volume thereof presents a variation from small to large magnitudes in each case.
  • the corresponding pulse width is small; and for lipid granule particles of large diameters, the corresponding pulse width is large.
  • the pulse width of a lipid granule is equal to that of a leucocyte. As shown in Figs.
  • a lipid granule cluster A4 have from small to large pulse widths, and overlaps with a basophil granulocyte cluster B4 and a cluster C4 of other leucocyte particles in the small pulse width part. Consequently, the lipid granules and the leucocytes cannot be separated from each other favourably according to pulse width, no matter based on a forward-scattered light scatter diagram or on a side-scattered light scatter diagram.
  • a new reinforcement signal is formed by combining a function of an optical signal with a function of the pulse width signal, so that a scatter diagram generated based on the reinforcement signal can significantly enhance the effect of separating particle groups.
  • Fig. 5 shows a structural schematic diagram of a blood cell analyser.
  • the blood cell analyser comprises an optical detection apparatus 20, a conveying apparatus 30, a data processing device 40 and a display apparatus 50.
  • the conveying apparatus 30 is used to convey a sample liquid (e.g., a blood sample to be tested) after reaction with a reagent to the optical detection apparatus 20.
  • the conveying apparatus 30 typically comprises a conveying line and a control valve, where the sample liquid is conveyed into the optical detection apparatus 20 through the conveying line and the control valve.
  • the optical detection apparatus 20 is used for irradiating the sample liquid flowing through the detection region thereof with light, collecting various optical information (e.g., scattered light information and/or fluorescence information) generated by cells irradiated with light, and converting the optical information into corresponding electric signals.
  • the information corresponds to the characteristics of the cell particles and can be used as characteristic data of the cell particles.
  • the forward-scattered light signal reflects size information of the cell
  • the side-scattered light signal reflects complexity of an internal structure of the cell
  • the fluorescence signal reflects the content of matters in the cell that can be dyed by a fluorescent dye, such as DNA and RNA.
  • a fluorescent dye such as DNA and RNA.
  • the optical detection apparatus 20 can include a light source 1025, a detection region 1021 serving as the detection region, a forward-scattered light signal collecting device 1023 provided on an optical axis, a side-scattered light signal collecting device 1026 and a fluorescence signal collecting device 1027 provided at a side of the optical axis.
  • the fluorescence signal collecting device 1027 is not required.
  • a blood sample is separated as needed. Streams of sample liquid after reaction with different reagents pass through the detection region 1021 of a flow chamber 1022 in sequence with shrouding by a sheath liquid. A light beam emitted by the light source 1025 is projected to the detection region 1021. Cell particles in the sample liquid are irradiated with the light beam and then emit scattered light. The light collecting device collects the scattered light, and the collected and shaped light is projected to a photoelectric sensor. The photoelectric sensor converts the optical signal into a corresponding electrical signal and outputs the electrical signal to the data processing device 40.
  • the data processing device 40 is configured to receive optical information output from the optical detection apparatus 20, where the optical information of each particle is used as a characteristic data set characterizing the particle, and an analysis of the blood sample is realized by analysing and processing the characteristic data of the particles.
  • the data processing device 40 includes a particle sorting device that generates a desired scatter diagram based on the characteristic data sets of the particles and sorts the particles according to the scatter diagram.
  • the particle sorting device is used for distinguishing leucocytes from interfering particles, where the interfering particles may be aggregated blood platelet particles or lipid granules.
  • the scatter diagram refers to a set of characteristic data sets of the cell particles, which may be stored in a storage device in a digitized form, or may be presented in a visualized form on a display interface.
  • the display apparatus 50 is electrically coupled to the data processing device 40 to display the analysis result output by the data processing device 40, and the analysis result may be a graphic, a text description, a table, or the like.
  • the display apparatus 50 may output various visualized scatter diagrams and/or various cell sorting results.
  • a particle sorting device includes an optical signal acquisition unit 41, a pulse width acquisition unit 42, a calculating unit 43, a new scatter diagram generating unit 44 and a sorting unit 45.
  • the optical signal acquisition unit 41 is used for acquiring an optical signal.
  • the detection region is irradiated with light emitted by the optical detection apparatus 20, and particles in the sample are irradiated with the light to generate corresponding optical signals.
  • the optical detection apparatus 20 collects various optical information generated by the particles due to the light irradiation.
  • the optical signals include at least two of forward-scattered light, side-scattered light and fluorescence, for example, the forward-scattered light and the side-scattered light, or the forward-scattered light, the-side scattered light and the fluorescence.
  • the pulse width acquisition unit 42 is used for acquiring a pulse width of at least one optical signal.
  • the pulse width acquisition unit 42 selects an optical signal from the collected optical signals and records the pulse width of this optical signal, for example, it can record the pulse width of the forward-scattered light, the side-scattered light or the fluorescence.
  • the pulse width acquisition unit 42 selects a plurality of optical signals from the collected optical signals and records the pulse width of each of the plurality of optical signals, for example, the pulse widths of both the forward-scattered light and the fluorescence.
  • the calculating unit 43 is used for calculating a reinforcement signal.
  • the reinforcement signal is calculated from the pulse width of an optical signal and a combined optical signal using a combinatorial function.
  • the combined optical signal may be any one of the optical signals obtained by the optical signal acquisition unit 41.
  • the combinatorial calculation increases the difference in the reinforcement signal between the leucocyte particles and the interfering particles relative to the difference between the two in the combined optical signal.
  • the function f has the following characteristics: the function f is monotonic for the combined optical signal or pulse width, i.e., when the combined optical signal is fixed (or constant), the function is a monotonic function for the pulse width, for example, the function is an increasing or decreasing function of the pulse width; and when the pulse width is fixed, the function is a monotonic function for the combined optical signal, for example, the function is an increasing or decreasing function of the combined optical signal.
  • the function f has the following characteristics: the function f is a non-linear combinatorial function of the combined optical signal and the pulse width.
  • the reinforcement signal obtained through the combinatorial calculation by the calculating unit 43 may comprise one type of signal, for example, the reinforcement signal is only a reinforcement signal of the forward-scattered light with the pulse width; the reinforcement signal obtained through combinatorial calculation by the calculating unit 43 may comprise a plurality of types of signal, for example, the reinforcement signal may be a reinforcement signal of the forward-scattered light with the pulse width, combined with a reinforcement signal of the side-scattered light with the pulse width.
  • the optical signal of which the pulse width is recorded and the combined optical signal may be the same optical signal or may be different optical signals.
  • the new scatter diagram generating unit 44 is used to form a new scatter diagram on the basis of the reinforcement signal and at least another signal, and the at least another signal may be at least one optical signal different from the combined optical signal, or at least one of or a combination of two of other reinforcement signals.
  • the new scatter diagram may be two-dimensional or three-dimensional, where at least one dimension is the reinforcement signal.
  • a new scatter diagram is formed by selecting an optical signal and a reinforcement signal, for example, selecting one optical signal and one reinforcement signal to form a two-dimensional new scatter diagram, or selecting one optical signal and two reinforcement signals to form a three-dimensional new scatter diagram, or selecting two optical signals and one reinforcement signal to form a three-dimensional new scatter diagram.
  • the combined optical signal for calculating the reinforcement signal is fluorescence
  • the forward-scattered light and the reinforcement signal are selected to form a new scatter diagram.
  • a certain reinforcement signal and other reinforcement signals are selected to form a new scatter diagram, where the other reinforcement signals refer to a reinforcement signal different from the certain reinforcement signal, for example, selecting an A-type reinforcement signal from the at least one reinforcement signal calculated by the calculating unit 43 as a dimension of the new scatter diagram, and then selecting a B-type reinforcement signal different from the A-type reinforcement signal as another dimension of the new scatter diagram.
  • the new scatter diagram selects two types of reinforcement signals to form a two-dimensional new scatter diagram, for example, selecting a reinforcement signal of the forward-scattered light and the pulse width, and a reinforcement signal of the side-scattered light and the pulse width to form a two-dimensional new scatter diagram.
  • the sorting unit 45 is used for distinguishing between the leucocyte particles and the interfering particles according to the new scatter diagram.
  • Leucocyte particles and interfering particles differ slightly in optical signal and pulse width, but the difference is not sufficient to distinguish between the leucocyte particles and the interfering particles.
  • the difference can be increased by combinatorial calculation of the optical signals and the pulse width. Since the reinforcement signal increases the difference in the reinforcement signal between the leucocyte particles and the interfering particles relative to the difference between the two in the combined optical signal, the leucocyte particles and the interfering particles can be distinguished from each other in a scatter diagram based at least on the reinforcement signal.
  • a conventional sorting method is used first, i.e., a scatter diagram is generated based on an optical signal, which is referred to as an initial scatter diagram.
  • a reinforcement signal of the optical signal and the pulse width signal are used then to distinguish between the leucocyte particles and the interfering particles.
  • a particle sorting device includes an optical signal acquisition unit 51, an initial scatter diagram generating unit 52, a pulse width acquisition unit 53, a calculating unit 54, a new scatter diagram generating unit 55 and a sorting unit 56.
  • the optical signal acquisition unit 51, the calculating unit 54 and the new scatter diagram generating unit 55 are the same as those in the foregoing example.
  • the initial scatter diagram generating unit 52 is used for generating an initial scatter diagram for sorting and/or counting the leucocytes according to an optical signal.
  • the pulse width acquisition unit 53 is used for acquiring a pulse width of at least one optical signal when there is an overlap region between a leucocyte particle cluster and an interfering particle cluster in the initial scatter diagram.
  • the sorting unit 56 is used for distinguishing between the leucocyte particles and the interfering particles and counting the leucocytes according to the new scatter diagram. When the leucocyte particle cluster and the interfering particle cluster have no overlap regions in the initial scatter diagram, the sorting unit 56 also counts the leucocytes according to the initial scatter diagram.
  • a blood platelet aggregation sample is taken as an example, the blood sample was measured by a blood cell analyser, and a leucocyte count can be obtained through an NRBC channel.
  • red blood cells and blood platelets will form cell debris after being treated with a hemolytic agent, and the cell debris will be located in a blood ghost part of lower-end signals in the NRBC channel after measurement by the blood cell analyser.
  • a NRBC channel scatter diagram of a normal sample is shown in Fig. 8 . It can be seen that the blood ghost A5 and leucocyte cluster B5 are significantly separated from each other, so that the blood ghost will not interfere with the leucocyte counting.
  • the hemolytic agent cannot dissolve the blood platelet favourably, so that aggregated blood platelets may remain in the blood sample, and the aggregated blood platelets have a high signal intensity and will overlap with a leucocyte group.
  • aggregated blood platelet particle group A1 and leucocyte group B1 overlap with each other, affecting the leucocyte counting through the NRBC channel.
  • a processing procedure of the present example is shown in Fig. 9 , comprising the following blocks:
  • optical signals generated by particles irradiated with light in a blood sample are acquired when the sample passes through a detection region, the optical signals including forward-scattered light, side-scattered light and fluorescence, and in the present example, the fluorescence being side fluorescence.
  • a pulse width of the forward-scattered light is recorded (hereinafter referred to as forward-scattered pulse width).
  • the reinforcement signal is calculated based on the pulse width.
  • the signal intensity of the fluorescence signal is multiplied by the forward-scattered pulse width to obtain a fluorescence - forward-scattered pulse width reinforcement signal.
  • the forward-scattered light and the fluorescence - forward-scattered pulse width reinforcement signal are selected to form a new scatter diagram.
  • the abscissa is the fluorescence - forward-scattered pulse width reinforcement signal
  • the ordinate is the forward-scattered light
  • A1 is the aggregated blood platelet particle group
  • B1 is the leucocyte particle cluster.
  • the particles are sorted and/or counted according to the new scatter diagram.
  • the leucocyte particles and the interfering particles are distinguished from each other according to the new scatter diagram.
  • the pulse width of the platelets tends to be greater than the pulse width of the leucocyte particles.
  • the aggregated blood platelet particle group A1 is located on the lower right side of the leucocyte particle cluster B1.
  • the fluorescence intensity of the blood platelet particles is greater than the fluorescence intensity of the leucocyte particles, or the fluorescence intensity at the centre of the aggregated blood platelet particle group A1 is greater than the fluorescence intensity at the centre of the leucocyte particle cluster B1.
  • the aggregated blood platelet particle group A1 is shifted more to the right relative to the leucocyte particle cluster B1, so that the overlap region between the aggregated blood platelet particle group A1 and the leucocyte particle cluster B1 is eliminated. Therefore, the leucocyte particles and the blood platelets can be distinguished from each other more easily and more accurately in the new scatter diagram.
  • the forward-scattered light may also be selected as a combined optical signal, and the reinforcement signal is a quotient of a forward-scattered light increasing function and a pulse width increasing function, for example, dividing the signal intensity of the forward-scattered light by the forward-scattered pulse width to obtain a forward-scattered - forward-scattered pulse width reinforcement signal.
  • the side-scattered fluorescence and the forward-scattered - forward-scattered pulse width reinforcement signal are selected to form a new scatter diagram, as shown in Fig. 11 .
  • the pulse width of the platelets is greater than the pulse width of the leucocyte particles. According to Fig.
  • the forward-scattered light intensity of the blood platelet particles is less than the forward-scattered light intensity of the leucocyte particles, or the forward-scattered light intensity at the centre of the aggregated blood platelet particle group A1 is less than the forward-scattered light intensity at the centre of the leucocyte particle cluster B1.
  • the reinforcement signal is the forward-scattered light intensity divided by the forward-scattered pulse width, and therefore, in the new scatter diagram, the aggregated blood platelet particle group A1 will become smaller in the direction of the reinforcement signal, while the leucocyte particle cluster B1 will become greater in the direction of the reinforcement signal, so that the difference between the leucocyte particles and the aggregated blood platelet particles is greater, and the leucocyte particles and the aggregated blood platelet particles can be distinguished from each other more easily and more accurately.
  • the pulse width may also be the pulse width of side-scattered light or fluorescence.
  • the pulse width is the pulse width of the side-scattered light (referred to as side-scattered pulse width)
  • the reinforcement signal is the product of the fluorescence and the side-scattered pulse width (referred to as fluorescence - side-scattered pulse width reinforcement signal).
  • the forward-scattered light and the fluorescence - side-scattered pulse width reinforcement signal are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • the pulse width is the pulse width of the side-scattered light (referred to as side-scattered pulse width)
  • the reinforcement signal is the quotient of the forward-scattered light divided by the side-scattered pulse width (referred to as forward-scattered - side-scattered pulse width reinforcement signal).
  • the forward-scattered light - side-scattered pulse width reinforcement signal and the fluorescence are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • the pulse width is the pulse width of the fluorescence (referred to as fluorescence pulse width)
  • the reinforcement signal is the product of the fluorescence multiplied by the fluorescence pulse width (referred to as fluorescence - fluorescence pulse width reinforcement signal).
  • the forward-scattered light and the fluorescence - fluorescence pulse width reinforcement signal are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • the reinforcement signal can be regarded as an approximately triangular shape, and in the present example, the reinforcement signal is the product of the fluorescence multiplied by the fluorescence pulse width, the reinforcement signal can be considered to be twice the area of the fluorescent pulse signal. That is, when the combined optical signal intensity and the pulse width for calculating the reinforcement signal belong to the same optical signal, the reinforcement signal may be the area of or several times the area of the pulse signal of a certain type of light, which may be regarded as a special case of the reinforcement signal.
  • the area of the optical pulse signal can be calculated by multiplying a pulse peak value by the pulse width according to the area formula of a triangle, or by accumulating or integrating the optical signal within the pulse width.
  • the pulse width is the pulse width of the fluorescence (referred to as fluorescence pulse width)
  • the reinforcement signal is the quotient of the forward-scattered light divided by the fluorescence pulse width (referred to as forward-scattered - fluorescence pulse width reinforcement signal).
  • the forward-scattered light - fluorescence pulse width reinforcement signal and the fluorescence are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • a lipid granule sample is taken as an example, the blood sample was measured by a blood cell analyser, and a leucocyte count is obtained through a BASO channel.
  • a BASO channel scatter diagram of a normal sample is shown in Fig. 16 , where the abscissa is the side-scattered light signal, the ordinate is the forward-scattered light signal.
  • B6 is leucocytes other than basophil granulocytes, namely lymphocytes, monocytes, neutrophil granulocytes and eosinophil granulocytes, being a main leucocyte cluster.
  • A6 is basophil granulocytes;
  • C6 is blood ghost, that is, fragments of red blood cells and platelets after treatment with a hemolytic agent.
  • there is few blood ghost spots in the normal sample and the blood ghost are located below the main leucocyte cluster and greatly separated from the main leucocyte cluster, so that the leucocyte counting will not be interfered with.
  • B2 is leucocytes other than basophil granulocytes, namely lymphocytes, monocytes, neutrophil granulocytes and eosinophil granulocytes, being a main leucocyte cluster.
  • A2 is basophil granulocytes;
  • C2 is blood ghost, that is, fragments of red blood cells and platelets after treatment with a hemolytic agent.
  • the lipid granules overlap with the leucocyte group and affect the leucocyte counting. Consequently, the leucocytes and the lipid granules cannot be distinguished from each other by the side-scattered light and forward-scattered light signals.
  • a processing procedure of the present example is shown in Fig. 17 , including the following blocks:
  • optical signals generated by particles irradiated with light in a blood sample are acquired when the sample passes through a detection region for detection, the optical signals including forward-scattered light and side-scattered light.
  • an initial scatter diagram is generated according to the forward-scattered light and the side-scattered light, where the abscissa is the side-scattered light, and the ordinate is the forward-scattered light.
  • block 73 it is determined whether there is an overlap region between lipid granules and a leucocyte group in the initial scatter diagram. If there is no overlap region between lipid granules and a leucocyte group in the initial scatter diagram, as shown in Fig. 16 , block 74 is performed; and if there is an overlap region between lipid granules and a leucocyte group in the initial scatter diagram, as shown in Fig. 2 , block 75 is performed.
  • a pulse width of the forward-scattered light is recorded (hereinafter referred to as forward-scattered pulse width).
  • the reinforcement signal is calculated based on the pulse width.
  • the forward-scattered light is selected as a combined optical signal, the reinforcement signal is the product of a forward-scattered light increasing function and a pulse width increasing function.
  • the intensity of the forward-scattered light signal is multiplied by the forward-scattered pulse width to obtain a forward-scattered light - forward-scattered pulse width reinforcement signal.
  • the side-scattered light and the forward-scattered light - forward-scattered pulse width reinforcement signal are selected to form a new scatter diagram.
  • the abscissa is the side-scattered light
  • the ordinate is the forward-scattered light - forward-scattered pulse width reinforcement signal
  • A2 is a basophil granulocyte cluster
  • B2 is a main leucocyte cluster
  • C2 is lipid granules.
  • the particles are sorted and/or counted according to the new scatter diagram.
  • the leucocyte particles and the interfering particles are distinguished from each other according to the new scatter diagram.
  • the lipid granules are located on the lower right side of the main leucocyte cluster B2.
  • the forward-scattered light intensity of the lipid granules is less than the forward-scattered light intensity of the leucocyte particles.
  • the pulse width of the lipid granules A4 is smaller than the pulse width of the main leucocyte cluster C4.
  • the lipid granules C2 are shifted more to the lower right side relative to the main leucocyte cluster B2, such that there is already an apparent empty space W between the lipid granules C2 and the main leucocyte cluster B2, as shown in an enlarged view on the right side of Fig. 18 . Therefore, the overlap between the lipid granules and the leucocyte cluster is avoided in the new scatter diagram, so that the leucocyte particles and the lipid granules can be distinguished from each other more easily and more accurately, thus facilitating the sorting.
  • block 75 is performed directly after block 71.
  • the intensity of the forward-scattered light signal may also be multiplied by the forward-scattered pulse width to the power of N (N is greater than 1) to obtain a forward-scattered light - forward-scattered pulse width reinforcement signal, for example, multiplying the intensity of the forward-scattered light signal by the square of the forward-scattered pulse width to obtain a reinforcement signal.
  • N is greater than 1
  • a new scatter diagram is formed by the side-scattered light and the reinforcement signal. As shown in Fig.
  • the lipid granules C2 are shifted more to the lower right side relative to the main leucocyte cluster B2, such that there is already an apparent empty space W between the lipid granules C2 and the main leucocyte cluster B2, as shown in an enlarged view on the right side of Fig. 19 . Therefore, the leucocyte particles and the lipid granules can also be distinguished from each other more easily and more accurately according to the new scatter diagram.
  • the abscissa and the ordinate of the new scatter diagram may be different reinforcement signals.
  • the abscissa is a side-scattered - forward-scattered pulse width reinforcement signal
  • the ordinate is a forward-scattered - forward-scattered pulse width reinforcement signal.
  • the pulse width may also be the pulse width of the side-scattered light.
  • the forward-scattered light may also be selected as a combined optical signal, and the reinforcement signal is a product of a forward-scattered light increasing function and a side-scattered pulse width increasing function, for example, multiplying the signal intensity of the forward-scattered light by the side-scattered pulse width to obtain a forward-scattered - side-scattered pulse width reinforcement signal.
  • the side-scattered fluorescence and the forward-scattered - side-scattered pulse width reinforcement signal are selected to form a new scatter diagram, where the main leucocyte cluster is shifted more to the upper left side relative to the lipid granules, such that the leucocyte particles and the lipid granules can also be distinguished from each other.
  • the reinforcement signal may be a function of the combined optical signal and the pulse width in order to obtain a scatter diagram that can distinguish between the leucocyte particles and the interfering particles, so long as the function increases the difference in the reinforcement signal between the leucocyte particles and the interfering particles relative to the difference between the two in the combined optical signal.
  • the above examples illustrate the distinguishing between leucocytes and lipid granules or aggregated PLT particles. According to the disclosed in the present application, it is to be understood by those skilled in the art that for two different categories of particles, if they differ in size in the overlap region, i.e., there are a difference in the pulse width between the two categories of particles in the overlap region, the above examples can also be used to distinguish between the two categories of particles, for example, a routine test for five types of leucocytes in certain scenes.
  • a new reinforcement signal can also be formed using functions of an optical signal and a pulse width signal, and the lymphocytes and monocytes can be distinguished from each other based on a scatter diagram generated by the reinforcement signal, thereby obtaining a more accurate result of the five types.
  • the storage medium may include a read-only memory, a random access memory, a disk or an optical disk, etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Signal Processing (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Description

    Technical Field
  • The present invention relates to a medical instrument, and more particularly to a cell analyser and a particle sorting method and device.
  • Background Art
  • A blood cell analyser is an instrument that can detect cells in the blood. It can count and sort cells such as leucocytes (white blood cells, WBC), red blood cells, blood platelets, nucleated red blood cells and reticulocytes.
  • The most common method used by a blood cell analyser to detect leucocytes is a laser scattering method, in which by irradiating cell particles flowing through a detection region with light, optical signals reflected or scattered by various categories of particles are collected, and then the optical signals are processed and analysed so as to sort and count the leucocytes. The collected optical signals may include three types of optical signals such as forward-scattered light, side-scattered light and fluorescence signals. The forward-scattered light can reflect size information of the cell, the side-scattered light can reflect complexity of an internal structure of the cell, and the fluorescence signal reflects the content of matters in the cell that can be dyed by a fluorescent dye, such as DNA and RNA. By means of these optical signals, the leucocytes can be sorted, and the leucocyte count can be obtained at the same time.
  • According to different pretreatments of blood samples (e.g., reagents being different), detection processes are divided into different detection channels, such as a DIFF channel, a BASO channel and a NRBC channel. The BASO channel is used to sort and count leucocytes, while a blood sample is treated with a chemical reagent, the total number of leucocytes is counted by means of side-scattered light and forward-scattered light, and a count of basophil granulocytes in the leucocytes is also provided. The NRBC channel can be used to sort nucleated red blood cells after a blood sample is treated with a fluorescent reagent added therein. The NRBC channel can provide a leucocyte count and a nucleated red blood cell count.
  • During blood cell detection by a blood cell analyser, two types of particles cannot be clearly distinguished from each other in some cases, thus affecting results of sorting the particles. For example, when counting leucocytes, the leucocytes may not be counted accurately due to the influence of interfering particles. The interfering particles may be lipid granules or aggregated PLT (blood platelet) particles. PLT is a part of a blood ghost which is a cell debris structure formed after a sample pretreatment of a blood sample, in which cells such as red blood cells or platelets are subjected to a hypotonic treatment or treated with a reagent, resulting in cell membrane rupture. Generally, the particle size is small, and the forward-scattered light signal is weak. However, in some samples, PLT aggregation may occur and interfering with the leucocyte detection. These interfering particles may overlap with the leucocyte in the scatter diagram. Fig. 1 shows a detection result of the NRBC channel, where an aggregated platelet cluster A1 overlaps with a leucocyte cluster B1 in the forward-scattered light and fluorescence signals. Fig. 2 shows a detection result of the BASO channel, where leucocytes are sorted into a basophil granulocyte cluster A2 and a cluster B2 of other leucocyte particles including lymphocytes, monocytes, neutrophil granulocytes and eosinophil granulocytes. Due to the exist of lipid particles, a lipid granule cluster C2 overlaps with the cluster B2 of other leucocyte particles in a region D2 at a lower end of the forward-scattered light and side-scattered light signals, which may interfere with counting of leucocytes. It can be seen that the exist of these interfering particles in the blood sample will affect the accuracy of the detection results.
  • US 2008/0176274 A1 describes a method for classifying and counting leukocytes, which includes staining cells and obtaining scattered light peak intensities and scattered light widths of respective cells based on a measured first scattered light and obtaining scattered light intensities of the respective cells based on a measured second scattered light, and obtaining fluorescence intensities of the respective cells based on the measured fluorescence light. The cells are then classified based on the scattered light peak intensities and scattered light widths.
  • Summary of the Invention
  • The invention is set out in the appended claims. The dependent claims set out particular embodiments. The embodiments or examples of the following description which are not covered by the appended claims are considered as not being part of the invention according to the description.
  • The invention relates to a particle sorting method, the method includes:
    • acquiring optical signals generated by particles irradiated with light in a blood sample when the sample passes through a detection region, the optical signals comprising at least two of forward-scattered light, side-scattered light and fluorescence;
    • acquiring at least one pulse width of at least one of the optical signals;
    • distinguishing between a first category of particles and a second category of particles according to a scatter diagram;
    • selecting at least one of the optical signals as a selected optical signal and using a signal intensity of the selected optical signal and the pulse width to calculate at least one reinforcement signal, depending on the number of pulse widths and/or signal intensities used for calculating the at least one reinforcement signal, the at least one reinforcement signal is a single reinforcement signal or a plurality of reinforcement signals including at least another reinforcement signal; and
    • forming the scatter diagram based on one reinforcement signal of the at least one reinforcement signal and at least another signal, wherein the at least another signal is either the another reinforcement signal of the at least one reinforcement signal or one of the optical signals which is different from the selected optical signa.
  • The invention also relates to a particle sorting device, the particle sorting device includes
    an optical signal acquisition unit for acquiring optical signals generated by particles irradiated with light in a blood sample when the sample passes through a detection region, the optical signals comprising at least two of forward-scattered light, side-scattered light and fluorescence;
    a pulse width acquisition unit for acquiring at least one pulse width of at least one of the optical signals;
    a sorting unit for distinguishing between a first category of particles and a second category of particles according to a scatter diagram;
    a calculating unit for selecting at least one of the optical signals as a selected optical signal, and using a signal intensity of the selected optical signal and the pulse width to calculate at least one reinforcement signal, depending on the number of pulse widths and/or signal intensities used for calculating the at least one reinforcement signal, the at least one reinforcement signal is a single reinforcement signal or a plurality of reinforcement signals including at least another reinforcement signal; and
    a scatter diagram generating unit for forming the scatter diagram based on a reinforcement signal of the at least one reinforcement signal and at least another signals, wherein the at least another signal is either the another reinforcement signal of the at least one reinforcement signal or one of the optical signals which is different from the selected optical signal
  • An embodiment of the invention provides a cell analyser comprising:
    • a conveying apparatus for conveying a sample liquid to be tested in an optical detection apparatus;
    • the optical detection apparatus for irradiating the sample liquid flowing through a detection region thereof with light, collecting various optical information generated by cells in the sample liquid irradiated with light, converting the optical information into corresponding electric signals and outputting the electric signals; and
    • the particle sorting device mentioned above for receiving and processing the electric signals outputed from the optical detection apparatus.
  • In the present disclosure, a new reinforcement signal is formed by combining a function of a certain optical signal and a function of a pulse width signal so that the difference between the first category of particles and the second category of particles in the reinforcement signal is increased, and a new scatter diagram is generated based on the reinforcement signal. By means of the greater difference between the first category of particles and the second category of particles in the reinforcement signal, the first category of particles and the second category of particles can be distinguished from each other, thereby improving the accuracy of particle sorting.
  • Brief Description of the Drawings
    • Fig. 1 is an NRBC channel scatter diagram of a blood platelet aggregation sample;
    • Fig. 2 is a BASO channel scatter diagram of a lipid granule sample;
    • Fig. 3 is a schematic diagram of a detected pulse;
    • Fig. 4a is a forward-scattered pulse width - forward-scattered light scatter diagram of the lipid granule sample;
    • Fig. 4b is a forward-scattered pulse width - side-scattered light scatter diagram of the lipid granule sample;
    • Fig. 5 is a structural schematic diagram of a blood cell analyser;
    • Fig. 6 is a structural schematic diagram of a particle sorting device in an embodiment;
    • Fig. 7 is a structural schematic diagram of a particle sorting device in another embodiment;
    • Fig. 8 is an NRBC channel scatter diagram of a normal sample;
    • Fig. 9 is a flow chart of NRBC channel particle sorting;
    • Fig. 10 is an NRBC channel scatter diagram with the fluorescence signal reinforced by the forward-scattered pulse width;
    • Fig. 11 is an NRBC channel scatter diagram with the forward-scattered light signal reinforced by the forward-scattered pulse width;
    • Fig. 12 is an NRBC channel scatter diagram with the fluorescence signal reinforced by the side-scattered pulse width;
    • Fig. 13 is an NRBC channel scatter diagram with the forward-scattered light signal reinforced by the side-scattered pulse width;
    • Fig. 14 is an NRBC channel scatter diagram with the fluorescence signal reinforced by the fluorescence pulse width;
    • Fig. 15 is an NRBC channel scatter diagram with the forward-scattered light signal reinforced by the fluorescence pulse width;
    • Fig. 16 is a BASO channel scatter diagram of the normal sample;
    • Fig. 17 is a flow chart of BASO channel particle sorting;
    • Fig. 18 is a BASO channel scatter diagram with the forward-scattered light signal reinforced by the forward-scattered pulse width; and
    • Fig. 19 is a BASO channel scatter diagram with the forward-scattered light signal reinforced by the square of the forward-scattered pulse width.
    Detailed Description of Embodiments
  • A particle passing through a detection region would generate a pulse, and the width of the pulse (hereinafter referred to as pulse width) can reflect the time during which the particle passes through the detection region, and thus can characterize the size of the particle. Fig. 3 shows a schematic diagram of a detected pulse, where a pulse signal is excited when a particle passes through a detection region. The pulse width is from the start of the pulse to the end of the pulse, and the pulse width signal is actually the time during which the particle passes through the detection region. When the flow rate is constant, the smaller the particle is, the shorter the time during which the particle passes through the detection region is, and in turn the smaller the corresponding pulse width will be; whereas the larger the particle is, the longer the time during which the particle passes through the detection region is, and in turn the greater the corresponding pulse width will be. Therefore, it is theoretically possible to distinguish between different kinds of particles by pulse width.
  • In a sample where platelet aggregation occurs, the width of a pulse generated by aggregated particles when passing through the detection region is relatively large. It is theoretically possible to distinguish between aggregated blood platelet particles and leucocytes by pulse width. However, due to the fact that the number of blood platelets aggregated together is different, the blood platelet clusters range widely in particle size, some aggregated blood platelet particles of a larger size will overlap with leucocyte groups. Therefore, the leucocytes and the aggregated blood platelet particles cannot be distinguished from each other favourably by pulse width.
  • With regard to lipid granules in a blood sample, because the size thereof varies, the volume thereof presents a variation from small to large magnitudes in each case. For lipid granule particles of small diameters, the corresponding pulse width is small; and for lipid granule particles of large diameters, the corresponding pulse width is large. In the case of a small pulse width, it is possible that the pulse width of a lipid granule is equal to that of a leucocyte. As shown in Figs. 4a and 4b, it can be seen that a lipid granule cluster A4 have from small to large pulse widths, and overlaps with a basophil granulocyte cluster B4 and a cluster C4 of other leucocyte particles in the small pulse width part. Consequently, the lipid granules and the leucocytes cannot be separated from each other favourably according to pulse width, no matter based on a forward-scattered light scatter diagram or on a side-scattered light scatter diagram.
  • Therefore, in exampless of the present disclosure, according to the difference in pulse width between the interfering particles and the leucocyte particles, a new reinforcement signal is formed by combining a function of an optical signal with a function of the pulse width signal, so that a scatter diagram generated based on the reinforcement signal can significantly enhance the effect of separating particle groups.
  • With reference to Fig. 5, Fig. 5 shows a structural schematic diagram of a blood cell analyser. The blood cell analyser comprises an optical detection apparatus 20, a conveying apparatus 30, a data processing device 40 and a display apparatus 50.
  • The conveying apparatus 30 is used to convey a sample liquid (e.g., a blood sample to be tested) after reaction with a reagent to the optical detection apparatus 20. The conveying apparatus 30 typically comprises a conveying line and a control valve, where the sample liquid is conveyed into the optical detection apparatus 20 through the conveying line and the control valve.
  • The optical detection apparatus 20 is used for irradiating the sample liquid flowing through the detection region thereof with light, collecting various optical information (e.g., scattered light information and/or fluorescence information) generated by cells irradiated with light, and converting the optical information into corresponding electric signals. The information corresponds to the characteristics of the cell particles and can be used as characteristic data of the cell particles. The forward-scattered light signal reflects size information of the cell, the side-scattered light signal reflects complexity of an internal structure of the cell, and the fluorescence signal reflects the content of matters in the cell that can be dyed by a fluorescent dye, such as DNA and RNA. In the example shown in Fig. 5, the optical detection apparatus 20 can include a light source 1025, a detection region 1021 serving as the detection region, a forward-scattered light signal collecting device 1023 provided on an optical axis, a side-scattered light signal collecting device 1026 and a fluorescence signal collecting device 1027 provided at a side of the optical axis. In some examples, the fluorescence signal collecting device 1027 is not required.
  • A blood sample is separated as needed. Streams of sample liquid after reaction with different reagents pass through the detection region 1021 of a flow chamber 1022 in sequence with shrouding by a sheath liquid. A light beam emitted by the light source 1025 is projected to the detection region 1021. Cell particles in the sample liquid are irradiated with the light beam and then emit scattered light. The light collecting device collects the scattered light, and the collected and shaped light is projected to a photoelectric sensor. The photoelectric sensor converts the optical signal into a corresponding electrical signal and outputs the electrical signal to the data processing device 40.
  • The data processing device 40 is configured to receive optical information output from the optical detection apparatus 20, where the optical information of each particle is used as a characteristic data set characterizing the particle, and an analysis of the blood sample is realized by analysing and processing the characteristic data of the particles. In the present example, the data processing device 40 includes a particle sorting device that generates a desired scatter diagram based on the characteristic data sets of the particles and sorts the particles according to the scatter diagram. In the examples of the present disclosure, the particle sorting device is used for distinguishing leucocytes from interfering particles, where the interfering particles may be aggregated blood platelet particles or lipid granules. In the examples of the present disclosure, the scatter diagram refers to a set of characteristic data sets of the cell particles, which may be stored in a storage device in a digitized form, or may be presented in a visualized form on a display interface.
  • The display apparatus 50 is electrically coupled to the data processing device 40 to display the analysis result output by the data processing device 40, and the analysis result may be a graphic, a text description, a table, or the like. In the present example, the display apparatus 50 may output various visualized scatter diagrams and/or various cell sorting results.
  • In one example, leucocyte particles and interfering particles are distinguished from each other by means of reinforcement signals of optical signals and pulse width signals, regardless of the presence or absence of the interfering particles and whether or not the interfering particles overlap with the leucocytes. As shown in Fig. 6, a particle sorting device includes an optical signal acquisition unit 41, a pulse width acquisition unit 42, a calculating unit 43, a new scatter diagram generating unit 44 and a sorting unit 45.
  • The optical signal acquisition unit 41 is used for acquiring an optical signal. When the blood sample passes through a detection region, the detection region is irradiated with light emitted by the optical detection apparatus 20, and particles in the sample are irradiated with the light to generate corresponding optical signals. The optical detection apparatus 20 collects various optical information generated by the particles due to the light irradiation. The optical signals include at least two of forward-scattered light, side-scattered light and fluorescence, for example, the forward-scattered light and the side-scattered light, or the forward-scattered light, the-side scattered light and the fluorescence.
  • The pulse width acquisition unit 42 is used for acquiring a pulse width of at least one optical signal. In some example, the pulse width acquisition unit 42 selects an optical signal from the collected optical signals and records the pulse width of this optical signal, for example, it can record the pulse width of the forward-scattered light, the side-scattered light or the fluorescence. In another particular example, the pulse width acquisition unit 42 selects a plurality of optical signals from the collected optical signals and records the pulse width of each of the plurality of optical signals, for example, the pulse widths of both the forward-scattered light and the fluorescence.
  • The calculating unit 43 is used for calculating a reinforcement signal. The reinforcement signal is calculated from the pulse width of an optical signal and a combined optical signal using a combinatorial function. The combined optical signal may be any one of the optical signals obtained by the optical signal acquisition unit 41. The combinatorial calculation increases the difference in the reinforcement signal between the leucocyte particles and the interfering particles relative to the difference between the two in the combined optical signal. For example, the reinforcement signal may be a function of the combined optical signal and the pulse width, which has an expression as follows: Z = f X Y
    Figure imgb0001
    where Z is the reinforcement signal; f is the function; X is the intensity of the combined optical signal, where in the examples of the present disclosure, the intensity of an optical signal can be the peak value of the optical pulse signal; and Y is the pulse width.
  • According to expression (1) above, the function f has the following characteristics:
    the function f is monotonic for the combined optical signal or pulse width, i.e., when the combined optical signal is fixed (or constant), the function is a monotonic function for the pulse width, for example, the function is an increasing or decreasing function of the pulse width; and when the pulse width is fixed, the function is a monotonic function for the combined optical signal, for example, the function is an increasing or decreasing function of the combined optical signal.
  • Alternatively, the function f has the following characteristics: the function f is a non-linear combinatorial function of the combined optical signal and the pulse width.
  • In some example, the reinforcement signal obtained through the combinatorial calculation by the calculating unit 43 may comprise one type of signal, for example, the reinforcement signal is only a reinforcement signal of the forward-scattered light with the pulse width; the reinforcement signal obtained through combinatorial calculation by the calculating unit 43 may comprise a plurality of types of signal, for example, the reinforcement signal may be a reinforcement signal of the forward-scattered light with the pulse width, combined with a reinforcement signal of the side-scattered light with the pulse width. In some example, the optical signal of which the pulse width is recorded and the combined optical signal may be the same optical signal or may be different optical signals.
  • The new scatter diagram generating unit 44 is used to form a new scatter diagram on the basis of the reinforcement signal and at least another signal, and the at least another signal may be at least one optical signal different from the combined optical signal, or at least one of or a combination of two of other reinforcement signals. The new scatter diagram may be two-dimensional or three-dimensional, where at least one dimension is the reinforcement signal. In some example, a new scatter diagram is formed by selecting an optical signal and a reinforcement signal, for example, selecting one optical signal and one reinforcement signal to form a two-dimensional new scatter diagram, or selecting one optical signal and two reinforcement signals to form a three-dimensional new scatter diagram, or selecting two optical signals and one reinforcement signal to form a three-dimensional new scatter diagram. In some implementation, it is able to select an optical signal different from the combined optical signal and a reinforcement signal to form a new scatter diagram. For example, if the combined optical signal for calculating the reinforcement signal is fluorescence, the forward-scattered light and the reinforcement signal are selected to form a new scatter diagram. In another particular example, a certain reinforcement signal and other reinforcement signals are selected to form a new scatter diagram, where the other reinforcement signals refer to a reinforcement signal different from the certain reinforcement signal, for example, selecting an A-type reinforcement signal from the at least one reinforcement signal calculated by the calculating unit 43 as a dimension of the new scatter diagram, and then selecting a B-type reinforcement signal different from the A-type reinforcement signal as another dimension of the new scatter diagram. That is, the new scatter diagram selects two types of reinforcement signals to form a two-dimensional new scatter diagram, for example, selecting a reinforcement signal of the forward-scattered light and the pulse width, and a reinforcement signal of the side-scattered light and the pulse width to form a two-dimensional new scatter diagram.
  • The sorting unit 45 is used for distinguishing between the leucocyte particles and the interfering particles according to the new scatter diagram. Leucocyte particles and interfering particles differ slightly in optical signal and pulse width, but the difference is not sufficient to distinguish between the leucocyte particles and the interfering particles. The difference can be increased by combinatorial calculation of the optical signals and the pulse width. Since the reinforcement signal increases the difference in the reinforcement signal between the leucocyte particles and the interfering particles relative to the difference between the two in the combined optical signal, the leucocyte particles and the interfering particles can be distinguished from each other in a scatter diagram based at least on the reinforcement signal.
  • In another example, a conventional sorting method is used first, i.e., a scatter diagram is generated based on an optical signal, which is referred to as an initial scatter diagram. When there is an overlap region in the initial scatter diagram between leucocyte particles and interfering particles, a reinforcement signal of the optical signal and the pulse width signal are used then to distinguish between the leucocyte particles and the interfering particles. As shown in Fig. 7, a particle sorting device includes an optical signal acquisition unit 51, an initial scatter diagram generating unit 52, a pulse width acquisition unit 53, a calculating unit 54, a new scatter diagram generating unit 55 and a sorting unit 56. The optical signal acquisition unit 51, the calculating unit 54 and the new scatter diagram generating unit 55 are the same as those in the foregoing example. The initial scatter diagram generating unit 52 is used for generating an initial scatter diagram for sorting and/or counting the leucocytes according to an optical signal. The pulse width acquisition unit 53 is used for acquiring a pulse width of at least one optical signal when there is an overlap region between a leucocyte particle cluster and an interfering particle cluster in the initial scatter diagram. The sorting unit 56 is used for distinguishing between the leucocyte particles and the interfering particles and counting the leucocytes according to the new scatter diagram. When the leucocyte particle cluster and the interfering particle cluster have no overlap regions in the initial scatter diagram, the sorting unit 56 also counts the leucocytes according to the initial scatter diagram.
  • In the following, the disclosure is described in detail by examples of specific blood samples.
  • In one example, a blood platelet aggregation sample is taken as an example, the blood sample was measured by a blood cell analyser, and a leucocyte count can be obtained through an NRBC channel.
  • In general, red blood cells and blood platelets will form cell debris after being treated with a hemolytic agent, and the cell debris will be located in a blood ghost part of lower-end signals in the NRBC channel after measurement by the blood cell analyser. A NRBC channel scatter diagram of a normal sample is shown in Fig. 8. It can be seen that the blood ghost A5 and leucocyte cluster B5 are significantly separated from each other, so that the blood ghost will not interfere with the leucocyte counting.
  • When there is blood platelet aggregation in a blood sample, the hemolytic agent cannot dissolve the blood platelet favourably, so that aggregated blood platelets may remain in the blood sample, and the aggregated blood platelets have a high signal intensity and will overlap with a leucocyte group. As shown in Fig. 1, aggregated blood platelet particle group A1 and leucocyte group B1 overlap with each other, affecting the leucocyte counting through the NRBC channel.
  • Thus, a processing procedure of the present example is shown in Fig. 9, comprising the following blocks:
    In block 61, optical signals generated by particles irradiated with light in a blood sample are acquired when the sample passes through a detection region, the optical signals including forward-scattered light, side-scattered light and fluorescence, and in the present example, the fluorescence being side fluorescence.
  • In block 62, a pulse width of the forward-scattered light is recorded (hereinafter referred to as forward-scattered pulse width).
  • In block 63, the reinforcement signal is calculated based on the pulse width. The fluorescence signal is selected as a combined optical signal, and the reinforcement signal is the product of a fluorescence signal increasing function and a pulse width increasing function, with a formula as follows: Z 1 = fx fy
    Figure imgb0002
    where Z1 is a fluorescence - forward-scattered pulse width reinforcement signal, fx is an increasing function of the intensity of the fluorescence signal, and fy is an increasing function of the forward-scattered pulse width.
  • In some example, the signal intensity of the fluorescence signal is multiplied by the forward-scattered pulse width to obtain a fluorescence - forward-scattered pulse width reinforcement signal.
  • In block 64, the forward-scattered light and the fluorescence - forward-scattered pulse width reinforcement signal are selected to form a new scatter diagram. As shown in Fig. 10, the abscissa is the fluorescence - forward-scattered pulse width reinforcement signal, the ordinate is the forward-scattered light, A1 is the aggregated blood platelet particle group, and B1 is the leucocyte particle cluster.
  • In block 65, the particles are sorted and/or counted according to the new scatter diagram. In the present example, the leucocyte particles and the interfering particles are distinguished from each other according to the new scatter diagram. Typically, in the overlap region, the pulse width of the platelets tends to be greater than the pulse width of the leucocyte particles. According to Fig. 1, the aggregated blood platelet particle group A1 is located on the lower right side of the leucocyte particle cluster B1. In the direction of the fluorescence, where the forward-scattered light is the same, the fluorescence intensity of the blood platelet particles is greater than the fluorescence intensity of the leucocyte particles, or the fluorescence intensity at the centre of the aggregated blood platelet particle group A1 is greater than the fluorescence intensity at the centre of the leucocyte particle cluster B1. After multiplying the fluorescence intensities of the blood platelets and the leucocyte particles respectively by the pulse width, as for the multiplication of the large factors, the product will be even larger, whilst for the multiplication of the small factors, the product will be even smaller, the difference in the reinforcement signal between the blood platelets and the leucocyte particles is greater, and is increased relative to the difference in the fluorescence signal between the two. As shown in Fig. 10, the aggregated blood platelet particle group A1 is shifted more to the right relative to the leucocyte particle cluster B1, so that the overlap region between the aggregated blood platelet particle group A1 and the leucocyte particle cluster B1 is eliminated. Therefore, the leucocyte particles and the blood platelets can be distinguished from each other more easily and more accurately in the new scatter diagram.
  • In block 63, the forward-scattered light may also be selected as a combined optical signal, and the reinforcement signal is a quotient of a forward-scattered light increasing function and a pulse width increasing function, for example, dividing the signal intensity of the forward-scattered light by the forward-scattered pulse width to obtain a forward-scattered - forward-scattered pulse width reinforcement signal. In block 64, the side-scattered fluorescence and the forward-scattered - forward-scattered pulse width reinforcement signal are selected to form a new scatter diagram, as shown in Fig. 11. Likewise, in the overlap region, the pulse width of the platelets is greater than the pulse width of the leucocyte particles. According to Fig. 1, in the direction of the forward-scattered light, where the fluorescence is the same, the forward-scattered light intensity of the blood platelet particles is less than the forward-scattered light intensity of the leucocyte particles, or the forward-scattered light intensity at the centre of the aggregated blood platelet particle group A1 is less than the forward-scattered light intensity at the centre of the leucocyte particle cluster B1. Moreover, the reinforcement signal is the forward-scattered light intensity divided by the forward-scattered pulse width, and therefore, in the new scatter diagram, the aggregated blood platelet particle group A1 will become smaller in the direction of the reinforcement signal, while the leucocyte particle cluster B1 will become greater in the direction of the reinforcement signal, so that the difference between the leucocyte particles and the aggregated blood platelet particles is greater, and the leucocyte particles and the aggregated blood platelet particles can be distinguished from each other more easily and more accurately.
  • In other example, the pulse width may also be the pulse width of side-scattered light or fluorescence.
  • As shown in Fig. 12, the pulse width is the pulse width of the side-scattered light (referred to as side-scattered pulse width), and the reinforcement signal is the product of the fluorescence and the side-scattered pulse width (referred to as fluorescence - side-scattered pulse width reinforcement signal). The forward-scattered light and the fluorescence - side-scattered pulse width reinforcement signal are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • As shown in Fig. 13, the pulse width is the pulse width of the side-scattered light (referred to as side-scattered pulse width), and the reinforcement signal is the quotient of the forward-scattered light divided by the side-scattered pulse width (referred to as forward-scattered - side-scattered pulse width reinforcement signal). The forward-scattered light - side-scattered pulse width reinforcement signal and the fluorescence are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • As shown in Fig. 14, the pulse width is the pulse width of the fluorescence (referred to as fluorescence pulse width), and the reinforcement signal is the product of the fluorescence multiplied by the fluorescence pulse width (referred to as fluorescence - fluorescence pulse width reinforcement signal). The forward-scattered light and the fluorescence - fluorescence pulse width reinforcement signal are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • Since the pulse signal can be regarded as an approximately triangular shape, and in the present example, the reinforcement signal is the product of the fluorescence multiplied by the fluorescence pulse width, the reinforcement signal can be considered to be twice the area of the fluorescent pulse signal. That is, when the combined optical signal intensity and the pulse width for calculating the reinforcement signal belong to the same optical signal, the reinforcement signal may be the area of or several times the area of the pulse signal of a certain type of light, which may be regarded as a special case of the reinforcement signal. In this case, it is to be understood by those skilled in the art that even if the area of or several times the area of the optical pulse signal are taken as the reinforcement signal, it should still be regarded as a combinatorial calculation of the signal intensity and pulse width of a combined optical signal. In addition, the area of the optical pulse signal can be calculated by multiplying a pulse peak value by the pulse width according to the area formula of a triangle, or by accumulating or integrating the optical signal within the pulse width.
  • As shown in Fig. 15, the pulse width is the pulse width of the fluorescence (referred to as fluorescence pulse width), and the reinforcement signal is the quotient of the forward-scattered light divided by the fluorescence pulse width (referred to as forward-scattered - fluorescence pulse width reinforcement signal). The forward-scattered light - fluorescence pulse width reinforcement signal and the fluorescence are selected to form a new scatter diagram. According to the new scatter diagram, the leucocyte particle cluster B1 and the aggregated blood platelet particle group A1 can also be distinguished from each other more easily and more accurately.
  • In another example, a lipid granule sample is taken as an example, the blood sample was measured by a blood cell analyser, and a leucocyte count is obtained through a BASO channel.
  • There is no lipid granules in a normal sample in the BASO channel, so that the leucocyte count is accurate. A BASO channel scatter diagram of a normal sample is shown in Fig. 16, where the abscissa is the side-scattered light signal, the ordinate is the forward-scattered light signal. B6 is leucocytes other than basophil granulocytes, namely lymphocytes, monocytes, neutrophil granulocytes and eosinophil granulocytes, being a main leucocyte cluster. A6 is basophil granulocytes; C6 is blood ghost, that is, fragments of red blood cells and platelets after treatment with a hemolytic agent. As can be seen from Fig. 16, there is few blood ghost spots in the normal sample, and the blood ghost are located below the main leucocyte cluster and greatly separated from the main leucocyte cluster, so that the leucocyte counting will not be interfered with.
  • When there are lipid granules in the blood sample, an S-shaped curve will be formed in the BASO channel, as shown in Fig. 2, where the abscissa is the side-scattered light signal, and the ordinate is the forward-scattered light signal. B2 is leucocytes other than basophil granulocytes, namely lymphocytes, monocytes, neutrophil granulocytes and eosinophil granulocytes, being a main leucocyte cluster. A2 is basophil granulocytes; C2 is blood ghost, that is, fragments of red blood cells and platelets after treatment with a hemolytic agent. In particular, at the lower end of the side-scattered light signal and the forward-scattered light signal, the lipid granules overlap with the leucocyte group and affect the leucocyte counting. Consequently, the leucocytes and the lipid granules cannot be distinguished from each other by the side-scattered light and forward-scattered light signals.
  • To reduce the influence of lipid granules on the leucocyte counting, a processing procedure of the present example is shown in Fig. 17, including the following blocks:
    In block 71, optical signals generated by particles irradiated with light in a blood sample are acquired when the sample passes through a detection region for detection, the optical signals including forward-scattered light and side-scattered light.
  • In block 72, an initial scatter diagram is generated according to the forward-scattered light and the side-scattered light, where the abscissa is the side-scattered light, and the ordinate is the forward-scattered light.
  • In block 73, it is determined whether there is an overlap region between lipid granules and a leucocyte group in the initial scatter diagram. If there is no overlap region between lipid granules and a leucocyte group in the initial scatter diagram, as shown in Fig. 16, block 74 is performed; and if there is an overlap region between lipid granules and a leucocyte group in the initial scatter diagram, as shown in Fig. 2, block 75 is performed.
  • In block 74, sorting and/or counting the leucocytes according to the initial scatter diagram.
  • In block 75, a pulse width of the forward-scattered light is recorded (hereinafter referred to as forward-scattered pulse width).
  • In block 76, the reinforcement signal is calculated based on the pulse width. The forward-scattered light is selected as a combined optical signal, the reinforcement signal is the product of a forward-scattered light increasing function and a pulse width increasing function. In some example, the intensity of the forward-scattered light signal is multiplied by the forward-scattered pulse width to obtain a forward-scattered light - forward-scattered pulse width reinforcement signal.
  • In block 77, the side-scattered light and the forward-scattered light - forward-scattered pulse width reinforcement signal are selected to form a new scatter diagram. As shown in Fig. 18, the abscissa is the side-scattered light, the ordinate is the forward-scattered light - forward-scattered pulse width reinforcement signal, A2 is a basophil granulocyte cluster, B2 is a main leucocyte cluster, and C2 is lipid granules.
  • In block 78, the particles are sorted and/or counted according to the new scatter diagram. In the present example, the leucocyte particles and the interfering particles are distinguished from each other according to the new scatter diagram. As shown in Fig. 2, in the region D2 where the lipid granules overlap with the leucocyte group, the lipid granules are located on the lower right side of the main leucocyte cluster B2. In the direction of the forward-scattered light, where the side-scattered light is the same, the forward-scattered light intensity of the lipid granules is less than the forward-scattered light intensity of the leucocyte particles. As shown in Figs. 4a and 4b, at the lower end of the forward-scattered light signal, the pulse width of the lipid granules A4 is smaller than the pulse width of the main leucocyte cluster C4. After multiplying the forward-scattered light intensities of the lipid granules and the leucocyte particles respectively by the pulse width, as for the multiplication of the large factors, the product will be even larger, whilst for the multiplication of the small factors, the product will be even smaller, the difference in the reinforcement signal between the lipid granules and leucocyte particles is greater, and is increased relative to the difference in the forward-scattered light signal between the two. As shown in Fig. 18, the lipid granules C2 are shifted more to the lower right side relative to the main leucocyte cluster B2, such that there is already an apparent empty space W between the lipid granules C2 and the main leucocyte cluster B2, as shown in an enlarged view on the right side of Fig. 18. Therefore, the overlap between the lipid granules and the leucocyte cluster is avoided in the new scatter diagram, so that the leucocyte particles and the lipid granules can be distinguished from each other more easily and more accurately, thus facilitating the sorting.
  • In the present example, it is also possible not to determine whether or not there is an overlap region according to an initial scatter diagram, and instead, block 75 is performed directly after block 71.
  • In block 76, after selecting the forward-scattered light as a combined optical signal, the intensity of the forward-scattered light signal may also be multiplied by the forward-scattered pulse width to the power of N (N is greater than 1) to obtain a forward-scattered light - forward-scattered pulse width reinforcement signal, for example, multiplying the intensity of the forward-scattered light signal by the square of the forward-scattered pulse width to obtain a reinforcement signal. A new scatter diagram is formed by the side-scattered light and the reinforcement signal. As shown in Fig. 19, the lipid granules C2 are shifted more to the lower right side relative to the main leucocyte cluster B2, such that there is already an apparent empty space W between the lipid granules C2 and the main leucocyte cluster B2, as shown in an enlarged view on the right side of Fig. 19. Therefore, the leucocyte particles and the lipid granules can also be distinguished from each other more easily and more accurately according to the new scatter diagram.
  • In other examples, the abscissa and the ordinate of the new scatter diagram may be different reinforcement signals. For example, the abscissa is a side-scattered - forward-scattered pulse width reinforcement signal, and the ordinate is a forward-scattered - forward-scattered pulse width reinforcement signal.
  • In a further example, the pulse width may also be the pulse width of the side-scattered light. In block 76, the forward-scattered light may also be selected as a combined optical signal, and the reinforcement signal is a product of a forward-scattered light increasing function and a side-scattered pulse width increasing function, for example, multiplying the signal intensity of the forward-scattered light by the side-scattered pulse width to obtain a forward-scattered - side-scattered pulse width reinforcement signal. In block 77, the side-scattered fluorescence and the forward-scattered - side-scattered pulse width reinforcement signal are selected to form a new scatter diagram, where the main leucocyte cluster is shifted more to the upper left side relative to the lipid granules, such that the leucocyte particles and the lipid granules can also be distinguished from each other.
  • According to the above disclosure, it is to be understood by those skilled in the art that the reinforcement signal may be a function of the combined optical signal and the pulse width in order to obtain a scatter diagram that can distinguish between the leucocyte particles and the interfering particles, so long as the function increases the difference in the reinforcement signal between the leucocyte particles and the interfering particles relative to the difference between the two in the combined optical signal.
  • The above examples illustrate the distinguishing between leucocytes and lipid granules or aggregated PLT particles. According to the disclosed in the present application, it is to be understood by those skilled in the art that for two different categories of particles, if they differ in size in the overlap region, i.e., there are a difference in the pulse width between the two categories of particles in the overlap region, the above examples can also be used to distinguish between the two categories of particles, for example, a routine test for five types of leucocytes in certain scenes. When there is an overlap region between two categories of particles, such as lymphocytes and a monocyte cluster having an overlap region, according to different pulse widths of the particles of the lymphocytes and the monocyte cluster in the overlap region, a new reinforcement signal can also be formed using functions of an optical signal and a pulse width signal, and the lymphocytes and monocytes can be distinguished from each other based on a scatter diagram generated by the reinforcement signal, thereby obtaining a more accurate result of the five types.
  • It is to be understood by those skilled in the art that all or some of the blocks of the various methods in the examples described above could be achieved by hardware commanded by a program, which program can be stored in a computer-readable storage medium. The storage medium may include a read-only memory, a random access memory, a disk or an optical disk, etc.
  • The present disclosure has been set forth with reference to specific examples, which are merely for the purpose of facilitating the understanding of the present disclosure and are not intended to limit the present disclosure. It will be apparent to those of ordinary skill in the art that changes may be made to the specific examples described above in accordance with the teachings of the present disclosure.

Claims (14)

  1. A particle sorting method, comprising:
    acquiring optical signals generated by particles irradiated with light in a blood sample when the sample passes through a detection region, the optical signals comprising at least two of forward-scattered light, side-scattered light and fluorescence;
    acquiring at least one pulse width of at least one of the optical signals;
    distinguishing between a first category of particles and a second category of particles according to a scatter diagram;
    characterized by selecting at least one of the optical signals as a selected optical signal and using a signal intensity of the selected optical signal and the at least one pulse width to calculate at least one reinforcement signal, where depending on the number of pulse widths and/or signal intensities used for calculating the at least one reinforcement signal, the at least one reinforcement signal is a single reinforcement signal or a plurality of reinforcement signals including at least another reinforcement signal; and
    forming the scatter diagram based on one reinforcement signal of the at least one reinforcement signal and at least another signal, wherein the at least another signal is either the another reinforcement signal of the at least one reinforcement signal or one of the optical signals which is different from the selected optical signal.
  2. The method of claim 1, characterized in that acquiring a pulse width of at least one of the optical signals comprises:
    generating an initial scatter diagram for sorting and/or counting the particles according to the optical signals; and
    acquiring the pulse width of the at least one optical signal when there is an overlap region of a cluster of the first category of particles and a cluster of the second category of particles in the scatter diagram.
  3. The method of claim 1, characterized in that the pulse width is a forward-scattered light pulse width.
  4. The method of any of claims 1 to 3, characterized in that the reinforcement signal is a non-linear combination function of the selected optical signal and the pulse width; or the reinforcement signal is a function of the selected optical signal and the pulse width, the function being a monotonic function of the selected optical signal or the pulse width.
  5. The method of claim 4, characterized in that the first category of particles are leucocyte particles, and the second category of particles are interfering particles that interfere with leucocyte counting.
  6. The method of claim 5, characterized in that the optical signals are detected through a BASO channel, the optical signals comprising forward-scattered light and side-scattered light, the pulse width being a pulse width of the forward-scattered light or the side-scattered light; and preferably, the selected optical signal is forward-scattered light, and the reinforcement signal is a product of a forward-scattered light increasing function and a pulse width increasing function.
  7. The method of claim 5, characterized in that the optical signals are detected through an NRBC channel, the optical signals comprising fluorescence and scattered light, the scattered light comprising at least one of forward-scattered light and side-scattered light, the pulse width being a pulse width of the forward-scattered light, the side-scattered light or the fluorescence; and preferably, the selected optical signal is forward-scattered light, and the reinforcement signal is a quotient of a forward-scattered light increasing function and a pulse width increasing function; or the selected optical signal is the fluorescence, and the reinforcement signal is a product of a fluorescence increasing function and the pulse width increasing function.
  8. A particle sorting device comprising:
    an optical signal acquisition unit (41, 51) for acquiring optical signals generated by particles irradiated with light in a blood sample when the sample passes through a detection region, the optical signals comprising at least two of forward-scattered light, side-scattered light and fluorescence;
    a pulse width acquisition unit (42, 53) for acquiring at least one pulse width of at least one of the optical signals;
    a sorting unit (45, 56) for distinguishing between a first category of particles and a second category of particles according to a scatter diagram;
    characterised by:
    a calculating unit (43, 54) for selecting at least one of the optical signals as a selected optical signal, and using a signal intensity of the selected optical signal and the at least one pulse width to calculate at least one reinforcement signal, wherein depending on the number of pulse widths and/or signal intensities used for calculating the at least one reinforcement signal, the at least one reinforcement signal is a single reinforcement signal or a plurality of reinforcement signals including at least another reinforcement signal; and
    a scatter diagram generating unit (44, 55) for forming the scatter diagram based on a reinforcement signal of the at least one reinforcement signal and at least another signal, wherein the at least another signal is either the another reinforcement signal of the at least one reinforcement signal or one of the optical signals which is different from the selected optical signal.
  9. The device of claim 8, characterized in that further comprising:
    a scatter diagram generating unit (52) for generating an initial scatter diagram for sorting and/or counting the particles according to the optical signals;
    the pulse width acquisition unit (53) for acquiring the pulse width of the at least one optical signal when there is an overlap region of a cluster of the first category of particles and a cluster of the second category of particles in the initial scatter diagram.
  10. The device of claim 8, characterized in that the reinforcement signal is a non-linear combination function of the selected optical signal and the pulse width; or the reinforcement signal is a function of the selected optical signal and the pulse width, the function being a monotonic function of the selected optical signal or the pulse width.
  11. The device of claim 10, characterized in that the first category of particles are leucocyte particles, and the second category of particles are interfering particles that interfere with leucocyte counting.
  12. The device of claim 11, characterized in that the optical signals are detected through a BASO channel, the optical signals comprising forward-scattered light and side-scattered light, the pulse width being a pulse width of the forward-scattered light or the side-scattered light; and preferably, the selected optical signal is forward-scattered light, and the reinforcement signal is a product of a forward-scattered light increasing function and a pulse width increasing function.
  13. The device of claim 11, characterized in that the optical signals are detected through an NRBC channel, the optical signals comprising fluorescence and scattered light, the scattered light comprising at least one of forward-scattered light and side-scattered light, the pulse width being a pulse width of the forward-scattered light, the side-scattered light or the fluorescence; and preferably, the selected optical signal is forward-scattered light, and the reinforcement signal is a quotient of a forward-scattered light increasing function and a pulse width increasing function; or the selected optical signal is the fluorescence, and the reinforcement signal is a product of a fluorescence increasing function and the pulse width increasing function.
  14. A cell analyser, characterized in that the cell analyser comprises:
    a conveying apparatus (30) for conveying a sample liquid to be tested in an optical detection apparatus (20);
    the optical detection apparatus (20) for irradiating the sample liquid flowing through a detection region (1021) thereof with light, collecting optical information generated by cells in the sample liquid irradiated with light, the optical information comprising at least one of forward-scattered light, side-scattered light and fluorescence, converting the optical information into corresponding electric signals and outputting the electric signals; and
    the particle sorting device of any one of claims 8 to 13 for receiving and processing the electric signals outputted from the optical detection apparatus.
EP15881526.6A 2015-02-12 2015-02-12 Cell analyzer and particle sorting method and device Active EP3258263B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP21194141.4A EP3943912A1 (en) 2015-02-12 2015-02-12 Cell analyzer and particle sorting method and device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2015/072907 WO2016127364A1 (en) 2015-02-12 2015-02-12 Cell analyzer and particle sorting method and device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP21194141.4A Division EP3943912A1 (en) 2015-02-12 2015-02-12 Cell analyzer and particle sorting method and device

Publications (3)

Publication Number Publication Date
EP3258263A1 EP3258263A1 (en) 2017-12-20
EP3258263A4 EP3258263A4 (en) 2018-09-12
EP3258263B1 true EP3258263B1 (en) 2021-09-01

Family

ID=56614033

Family Applications (2)

Application Number Title Priority Date Filing Date
EP15881526.6A Active EP3258263B1 (en) 2015-02-12 2015-02-12 Cell analyzer and particle sorting method and device
EP21194141.4A Pending EP3943912A1 (en) 2015-02-12 2015-02-12 Cell analyzer and particle sorting method and device

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP21194141.4A Pending EP3943912A1 (en) 2015-02-12 2015-02-12 Cell analyzer and particle sorting method and device

Country Status (4)

Country Link
US (4) US10330584B2 (en)
EP (2) EP3258263B1 (en)
CN (2) CN110244032B (en)
WO (1) WO2016127364A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3644041B1 (en) * 2017-06-20 2022-11-02 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Method and device for identifying platelet aggregation, and cell analyzer
WO2019206311A1 (en) 2018-04-28 2019-10-31 深圳迈瑞生物医疗电子股份有限公司 Blood analysis system, blood analyzer, blood analysis method, and storage medium
CN113316713B (en) 2018-10-17 2025-02-21 贝克顿·迪金森公司 Adaptive Sorting of Particle Analyzers
CN109580550A (en) * 2018-12-03 2019-04-05 迪瑞医疗科技股份有限公司 A kind of classification processing method and its device of leucocyte
WO2020133285A1 (en) * 2018-12-28 2020-07-02 深圳迈瑞生物医疗电子股份有限公司 Blood cell parameter correction method, blood sample detector and storage medium
CN113454453A (en) * 2019-05-08 2021-09-28 深圳迈瑞生物医疗电子股份有限公司 Whole blood sample analyzer, whole blood sample analyzing method, whole blood sample analyzing apparatus, and storage medium
CN114450590A (en) * 2019-07-25 2022-05-06 首尔伟傲世有限公司 Light irradiation device
CN111274949B (en) * 2020-01-19 2023-05-30 重庆医科大学附属第一医院 A method for similarity analysis of white blood cell scatter diagrams based on structure analysis
CN113959911B (en) * 2020-07-20 2024-06-18 深圳迈瑞生物医疗电子股份有限公司 Detection method and reagent for resisting platelet aggregation interference and application of detection method and reagent
JP7627556B2 (en) * 2020-08-28 2025-02-06 シスメックス株式会社 Measurement method, measurement device, and measurement program
CN114441785A (en) * 2020-11-06 2022-05-06 深圳美祥生物医疗科技有限公司 Bus type clinical blood analysis system based on programmable distributed control
CN112798769B (en) * 2021-01-28 2022-02-18 深圳市科曼医疗设备有限公司 Cell analysis method, device and cell analyzer of a cell analyzer
CN113686759B (en) * 2021-02-03 2023-11-24 深圳市帝迈生物技术有限公司 Kit and POCT blood cell analyzer
CN115219392A (en) * 2021-04-14 2022-10-21 深圳迈瑞生物医疗电子股份有限公司 Sample analyzer and sample analyzing method
CN114544469B (en) * 2022-04-25 2022-10-21 深圳市帝迈生物技术有限公司 Particle classification method and blood cell analyzer

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793185A (en) * 1971-12-23 1973-04-16 Atomic Energy Commission APPARATUS FOR QUICKLY ANALYZING AND SORTING PARTICLES SUCH AS BIOLOGICAL CELLS
US5559037A (en) * 1994-12-15 1996-09-24 Abbott Laboratories Method for rapid and simultaneous analysis of nucleated red blood cells
JP3305181B2 (en) * 1995-12-19 2002-07-22 シスメックス株式会社 Urine particle analyzer
US5861950A (en) * 1997-07-10 1999-01-19 Particle Measuring Systems, Inc. Particle detection system utilizing an inviscid flow-producing nozzle
US6734965B2 (en) * 2000-09-18 2004-05-11 Douglas G. Talley Optical patternation method
DE60326603D1 (en) * 2002-06-24 2009-04-23 Sysmex Corp PROCESS FOR CLASSIFICATION AND COUNTIFICATION OF LEUKOCYTES
JP4598766B2 (en) * 2003-04-29 2010-12-15 エス3アイ, エル エル シィ Multispectral optical method and system for detecting and classifying biological and non-biological microparticles
JP2007024844A (en) * 2005-07-21 2007-02-01 Sysmex Corp Method and system for hemanalysis
JP4976038B2 (en) * 2006-03-29 2012-07-18 シスメックス株式会社 Method for measuring hematological samples
JP4994920B2 (en) * 2007-02-01 2012-08-08 シスメックス株式会社 Sample analyzer
JP5006107B2 (en) * 2007-05-30 2012-08-22 シスメックス株式会社 Display method and blood analyzer
CN104122191B (en) * 2007-10-29 2020-02-18 希森美康株式会社 Cell analyzer and cell analysis method
US8628976B2 (en) * 2007-12-03 2014-01-14 Azbil BioVigilant, Inc. Method for the detection of biologic particle contamination
CN101498646B (en) * 2008-02-03 2014-06-11 深圳迈瑞生物医疗电子股份有限公司 Forward-scattering signal inspection device and method, cell or particle analyzer
EP2269038B1 (en) * 2008-03-21 2016-07-27 Abbott Point Of Care, Inc. Method for analyzing individual cells or particulates in blood using fluorescence and absorption of a colorant
JP5399647B2 (en) * 2008-03-28 2014-01-29 シスメックス株式会社 Sample analyzer and computer program
JP5420203B2 (en) 2008-06-30 2014-02-19 シスメックス株式会社 Sample analyzer, particle distribution map display method, and computer program
CN101672759B (en) * 2008-09-12 2013-01-23 深圳迈瑞生物医疗电子股份有限公司 Classified statistic method and device of particles
JP5537347B2 (en) * 2009-11-30 2014-07-02 シスメックス株式会社 Particle analyzer
WO2012158826A2 (en) * 2011-05-19 2012-11-22 Abbott Laboratories Method and apparatus for detection, analysis, and collection of rare cellular events
CN103091286B (en) * 2011-10-31 2016-08-17 深圳迈瑞生物医疗电子股份有限公司 The erythrocytic recognition methods of Infected With Plasmodium and device

Also Published As

Publication number Publication date
US20200191700A1 (en) 2020-06-18
EP3258263A4 (en) 2018-09-12
CN110244032B (en) 2021-01-12
CN110244032A (en) 2019-09-17
CN106662572A (en) 2017-05-10
WO2016127364A1 (en) 2016-08-18
US10983042B2 (en) 2021-04-20
US20200191701A1 (en) 2020-06-18
EP3943912A1 (en) 2022-01-26
US10883916B2 (en) 2021-01-05
US20190277746A1 (en) 2019-09-12
CN106662572B (en) 2019-07-05
EP3258263A1 (en) 2017-12-20
US20170350804A1 (en) 2017-12-07
US10627332B2 (en) 2020-04-21
US10330584B2 (en) 2019-06-25

Similar Documents

Publication Publication Date Title
US10983042B2 (en) Cell analyzer and sorting method therefor
US10222320B2 (en) Identifying and enumerating early granulated cells (EGCs)
US10337975B2 (en) Method and system for characterizing particles using a flow cytometer
US12216040B2 (en) Sample analyzer and sample analysis method
CN112673088A (en) Method for detecting white blood cells, blood cell analyzer and storage medium
CN105986003B (en) White blood cell counting method and device and cell analyzer
US11709123B2 (en) Method for analyzing nucleated red blood cells, blood cell analyzer, and storage medium
EP1714146A2 (en) Method of measurement of nucleated red blood cells
CN110887818A (en) Blood sample analysis method, blood cell analyzer and storage medium
EP4010682B1 (en) Detecting and reporting subpopulations of neutrophils
EP3244191B1 (en) Method and system for characterizing particles using a flow cytometer
CN115843332A (en) Sample analysis device and sample analysis method

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170811

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180813

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/49 20060101AFI20180807BHEP

Ipc: G01N 21/64 20060101ALI20180807BHEP

Ipc: G01N 15/14 20060101ALI20180807BHEP

Ipc: G01N 15/10 20060101ALI20180807BHEP

Ipc: G01N 21/53 20060101ALI20180807BHEP

Ipc: G01N 15/00 20060101ALI20180807BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200205

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZHANG, YING

Inventor name: WANG, GUANZHEN

Inventor name: YE, YI

Inventor name: DI, JIANTAO

Inventor name: YE, BO

Inventor name: QI, HUAN

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

INTG Intention to grant announced

Effective date: 20210707

RIN1 Information on inventor provided before grant (corrected)

Inventor name: YE, YI

Inventor name: WANG, GUANZHEN

Inventor name: YE, BO

Inventor name: QI, HUAN

Inventor name: ZHANG, YING

Inventor name: DI, JIANTAO

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1426746

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210915

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015072978

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20210901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211201

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211201

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1426746

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220101

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220103

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015072978

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

26N No opposition filed

Effective date: 20220602

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20220228

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220228

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220212

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220212

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20150212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210901

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250218

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20250221

Year of fee payment: 11